BIOMAT Database Logo BIOMAT Database Logo

Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects. 1989

B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
Section on Clinical Neuropharmacology, NIMH Bethesda, MD 20892.

The functional significance of alterations in brain serotonin (5HT) associated with normal aging in both animals and humans is largely unknown. Using the effects of the 5HT agonist, m-chlorophenylpiperazine (m-CPP), as a measure of central serotonergic responsivity, we compared the behavioral and neuroendocrine responses of older normal volunteers (mean age +/- SD = 62.4 +/- 4.12) to those of younger normal volunteers (mean age +/- SD = 31.6 +/- 5.52). When m-CPP was administered intravenously, older subjects showed decreased behavioral responses but similar neuroendocrine responses, compared to younger subjects. The decreased behavioral responsivity was unrelated to pharmaco-kinetic differences between the groups, since m-CPP plasma levels were similar in both groups. This report is the first in vivo study in humans to demonstrate decreased behavioral responsivity with age following serotonergic stimulation, and may indicate a functionally less responsive 5HT subsystem in older subjects.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain.
November 1995, Neuroreport,
B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
December 1985, The Journal of clinical endocrinology and metabolism,
B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.
January 1986, Psychopharmacology,
B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus.
July 2003, Neuroendocrinology,
B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine.
June 1988, Clinical pharmacology and therapeutics,
B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
Age-related alterations in behavioral and cerebral metabolic responses to the serotonin agonist meta-chlorophenylpiperazine in rats.
January 1991, Neurobiology of aging,
B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects.
January 1997, The American journal of psychiatry,
B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
November 1994, The American journal of psychiatry,
B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
November 2002, Pharmacopsychiatry,
B A Lawlor, and T Sunderland, and J L Hill, and A M Mellow, and S E Molchan, and E A Mueller, and F M Jacobsen, and D L Murphy
Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls.
April 1997, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!